Impact of Maternal COVID-19 on Neurodevelopment in Infants

Study Overview

A recent study examined the neurodevelopment of children whose mothers tested positive for COVID-19 during pregnancy. While COVID-19 is primarily a respiratory virus, emerging evidence indicates that its effects may extend beyond the respiratory system.

COVID-19 Complications

Symptoms of COVID-19 can vary widely, and some individuals, particularly those experiencing post-COVID conditions, may face various complications. Neurological symptoms such as brain fog, headaches, and sleep disturbances have been reported. This raises concerns about whether SARS-CoV-2 infection could affect fetal brain development.

Previous Research Insights

Research has suggested that maternal infections from different pathogens during pregnancy may be linked to neurodevelopmental issues in the fetus, even if these pathogens do not penetrate the placental barrier. The exact mechanisms of this relationship remain unclear, but inflammation from the mother’s immune response could create unfavorable conditions for fetal development.

Research Methodology

To explore the potential link between COVID-19 during pregnancy and neurodevelopmental effects in infants, a study published in JAMA Network Open was conducted. The researchers gathered data from two academic medical centers and six community hospitals across the United States. They screened mothers for COVID-19 by checking for positive results on a laboratory polymerase chain reaction (PCR) test at any point during their pregnancy. The primary outcome was whether the infants were diagnosed with a neurodevelopmental disorder within the first year of life.

Study Population and Results

The analysis included 7,772 live births from 7,466 pregnancies, with an average maternal age of 32.9 years. Among these, 222 infants were exposed to SARS-CoV-2 during pregnancy, while 7,550 were not. Notably, mothers who tested positive for COVID-19 were more likely to have public insurance and had a higher incidence of preterm deliveries.

The findings revealed that 14 of the 222 infants exposed to SARS-CoV-2, equating to 6.3%, received a neurodevelopmental diagnosis within the first year. In contrast, 227 of the 7,550 unexposed infants, or 3.0%, were diagnosed. Common diagnoses included issues related to motor function, language, and speech.

Limitations of the Study

It is important to acknowledge several limitations of this study. Firstly, neurodevelopmental diagnoses were only assessed at 12 months, which could underestimate the prevalence of certain disorders, such as Autism Spectrum Disorder, which are often identified later in childhood. Additionally, the study focused solely on officially diagnosed cases, potentially overlooking undiagnosed instances.

Conclusions and Future Research Directions

The study indicates that neurodevelopmental disorders were more prevalent among infants exposed to SARS-CoV-2 in utero. However, further research is necessary to ascertain whether COVID-19 during pregnancy is definitively linked to an increased risk of neurodevelopmental disorders in offspring. Additionally, understanding how to mitigate any potential impacts of COVID-19 on fetal development warrants further investigation.

References

1. Centers for Disease Control and Prevention (2022, May 5). Long COVID or Post-COVID Conditions. U.S. Department of Health & Human Services. Accessed 2022, June 16, from https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
2. Shook, L.L., Sullivan, E.L., Lo, J.O. (2022, April 1). COVID-19 in pregnancy: implications for fetal brain development. Review 28(4): P319-330. Doi: 10.1016/j.molmed.2022.02.004
3. Al-Haddad, B.J.S., Jacobsson, B., Chabra, S., et al (2019, March 6). Long-term risk of neuropsychiatric disease after exposure to infection in utero. JAMA Psychiatry 76(6): 594-602. Doi: 10.1001/jamapsychiatry.2019.0029
4. Cordeiro, C.N., Tsimis, M., Burd, I. (2016, March 17). Infections and brain development. Obstet Gynecol Surv 70(10): 644-655. Doi: 10.1097/OGX.0000000000000236
5. Edlow, A.G., Castro, V.M., Shook, L.L., et al (2022, June 9). Neurodevelopmental outcomes at 1 year in infants of mothers who tested positive for SARS-CoV-2 during pregnancy. JAMA Netw Open 5(6): e2215787. Doi: 10.1001/jamanetworkopen.2022.15787